Flemingsberg Science Foundation welcomes Ellen Mäkipiha as the new Communications Officer

In December last year, the Flemingsberg Science Foundation was granted funding from the European Regional Development Fund to establish itself as a key player in Life Science with the launch of the project “Cluster Engine Life Science Flemingsberg.” Meet Ellen Mäkipiha, the foundation’s new rising star, who will be working on the development of the Life Science cluster in Flemingsberg.

Ellen, tell us a little about yourself

– I’m a communications specialist with a background in journalism. Over the years, I have worked quite broadly within both fields, mainly as a writer but also in project management, research, strategic communication, and marketing. I thrive the most when I can continue learning in my role and through interactions with others—that has always been a driving force for me.

What are you most looking forward to in your new role?

– I am really looking forward to getting to know the ecosystem and the people here in Flemingsberg! To continue growing and to contribute to a meaningful environment filled with knowledge, ambition, and opportunities for collaboration.

What are your thoughts on Flemingsberg, both now and in the future?

– I have followed Flemingsberg’s development since childhood, from being a relatively anonymous area to becoming a thriving one—I live nearby and grew up in the area, studied at Södertörn University, and my children were born at Huddinge Hospital. Through this, I have become closely acquainted with the strong sense of engagement here, so it will be both exciting and rewarding to have the opportunity to contribute to the continued positive development of the area.

More about Ellen
When I’m not working, I spend time with my family and good friends, and I go to the theater, concerts, or museums as often as I can. Music and good food are especially close to my heart—so my home is rarely quiet, and the question I answer most often during the day is what we should have for dinner.

Read more about the project here >

 

Cellaviva: improving lives through stem cell technology

“Cellaviva was founded by researchers from Karolinska Institutet, in the belief that stem cells will revolutionize how complex and incurable diseases are treated. We are a biobank that helps expectant parents to save stem cells from the umbilical cord at birth, in a so-called family bank. The aim is to make high-quality, potent cells available quickly, if medical needs arise. This creates treatment opportunities and expands therapy options for the whole family,”

NextCell to treat type 1 diabetes in children with stem cells

NextCell Pharma in Flemingsberg has published extremely promising results from its clinical studies of drug candidate ProTrans for the treatment of type 1 diabetes. A study is now being carried out with the aim of examining its efficacy in children and young people.

Go to Top